Literature DB >> 10600328

Diagnostic guidelines--An International Consensus document.

M E Conley.   

Abstract

Mesh：

Year:  1999        PMID： 10600328     DOI： 10.1006/clim.1999.4798

Source DB:  PubMed          Journal:  Clin Immunol        ISSN： 1521-6616            Impact factor:   3.969


× No keyword cloud information.
  7 in total

Review 1.  X-linked lymphoproliferative syndrome.

Authors:  D L Nelson; C Terhorst
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

Review 2.  Lung Disease in Primary Antibody Deficiencies.

Authors:  Edith Schussler; Mary B Beasley; Paul J Maglione
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Nov - Dec

3.  A preliminary assessment of alpha-1 antitrypsin S and Z deficiency allele frequencies in common variable immunodeficiency patients with and without bronchiectasis.

Authors:  M E Sansom; B L Ferry; Z P M C Sherrell; H M Chapel
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

4.  Naturally occurring Bruton's tyrosine kinase mutations have no dominant negative effect in an X-linked agammaglobulinaemia cellular model.

Authors:  R Pérez de Diego; E López-Granados; J Rivera; A Ferreira; G Fontán; J Bravo; M C García Rodríguez; S Bolland
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

5.  Primary immunodeficiency in infection-prone children in southern Sweden: occurrence, clinical characteristics and immunological findings.

Authors:  Nicholas Brodszki; Göran Jönsson; Lillemor Skattum; Lennart Truedsson
Journal:  BMC Immunol       Date:  2014-08-14       Impact factor: 3.615

6.  Disseminated histoplasmosis in a patient with common variable immunodeficiency: A coincidence or the result of T cell defects?

Authors:  Molly E Johnson; Christian Rojas-Moreno; William Salzer; Hariharan Regunath
Journal:  IDCases       Date:  2017-10-18

Review 7.  Common variable immunodeficiency: an update.

Authors:  Ulrich Salzer; Klaus Warnatz; Hans Hartmut Peter
Journal:  Arthritis Res Ther       Date:  2012-09-24       Impact factor: 5.156
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.